A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE)

Pain

Volumn 149, Issue 3, 2010, Pages 565-572

  Olechowski, Camille Joanne ^a   Parmar, Ambica ^a   Miller, Brooke ^a   Stephan, Jared ^a   Tenorio, Gustavo ^a   Tran, Kristy ^b   Leighton, James ^b   Kerr, Bradley James ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

EAE; Formalin; Glutamate; Glutamate transporter; Pain

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; FORMALDEHYDE; GLUTAMATE TRANSPORTER; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SPINAL CORD;

AMINO ACID SEQUENCE; ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORMALDEHYDE; GLUTAMIC ACID; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PHOSPHORYLATION; RECEPTORS, METABOTROPIC GLUTAMATE; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 77952106356     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.03.037     Document Type: Article

References (44)

1. Aicher S.A., Silverman M.B., Winkler C.W., and Bebo Jr. B.F. Hyperalgesia in an animal model of multiple sclerosis. Pain 110 (2004) 560-570
2. Archibald C.J., McGrath P.J., Ritvo P.G., Fisk J.D., Bhan V., Maxner C.E., and Murray T.J. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 58 (1994) 89-93
3. Clifford D.B., and Trotter J.L. Pain in multiple sclerosis. Arch Neurol 41 (1984) 1270-1272
4. Coderre T.J., Fundytus M.E., McKenna J.E., Dalal S., and Melzack R. The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain 54 (1993) 43-50
5. Coderre T.J., and Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12 (1992) 3665-3670
6. Coderre T.J., Vaccarino A.L., and Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 535 (1990) 155-158
7. Danbolt N.C. Glutamate uptake. Prog Neurobiol 65 (2001) 1-105
8. + pump activity during electrogenic uptake of acidic amino acid transmitters by rat brain synaptosomes. J Neurochem 52 (1989) 135-139
9. Friese M.A., Craner M.J., Etzensperger R., Vergo S., Wemmie J.A., Welsh M.J., Vincent A., and Fugger L. Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat Med 13 (2007) 1483-1489
10. Gadea A., and Lopez-Colome A.M. Glial transporters for glutamate, glycine and GABA I. Glutamate transporters. J Neurosci Res 63 (2001) 453-460
11. Huang Y.H., and Bergles D.E. Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol 14 (2004) 346-352
12. Hunt S.P., Pini A., and Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328 (1987) 632-634
13. Jones C.K., Eberle E.L., Peters S.C., Monn J.A., and Shannon H.E. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology 49 (2005) 206-218
14. Liaw W.J., Stephens Jr. R.L., Binns B.C., Chu Y., Sepkuty J.P., Johns R.A., Rothstein J.D., and Tao Y.X. Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 115 (2005) 60-70
15. Lynch J.L., Gallus N.J., Ericson M.E., and Beitz A.J. Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis. Pain 136 (2008) 293-304
16. Maki R., Robinson M.B., and Dichter M.A. The glutamate uptake inhibitor l-trans-pyrrolidine-2,4-dicarboxylate depresses excitatory synaptic transmission via a presynaptic mechanism in cultured hippocampal neurons. J Neurosci 14 (1994) 6754-6762
17. McAdoo D.J., Xu G., Robak G., Hughes M.G., and Price E.M. Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord. Brain Res 865 (2000) 283-285
18. Moalem G., and Tracey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 51 (2006) 240-264
19. Moulin D.E., Foley K.M., and Ebers G.C. Pain syndromes in multiple sclerosis. Neurology 38 (1988) 1830-1834
20. Nakagawa T., Ozawa T., Shige K., Yamamoto R., Minami M., and Satoh M. Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol 419 (2001) 39-45
21. Niederberger E., Schmidtko A., Rothstein J.D., Geisslinger G., and Tegeder I. Modulation of spinal nociceptive processing through the glutamate transporter GLT-1. Neuroscience 116 (2003) 81-87
22. Ohgoh M., Hanada T., Smith T., Hashimoto T., Ueno M., Yamanishi Y., Watanabe M., and Nishizawa Y. Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 125 (2002) 170-178
23. Olechowski C.J., Truong J.J., and Kerr B.J. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain (2008)
24. Olechowski C.J., Truong J.J., and Kerr B.J. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 141 (2009) 156-164
25. Pampliega O., Domercq M., Villoslada P., Sepulcre J., Rodriguez-Antiguedad A., and Matute C. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol 195 (2008) 194-198
26. Phillis J.W., Ren J., and O'Regan M.H. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with dl-threo-beta-benzyloxyaspartate. Brain Res 868 (2000) 105-112
27. Price D.D., Hayes R.L., Ruda M., and Dubner R. Spatial and temporal transformations of input to spinothalamic tract neurons and their relation to somatic sensations. J Neurophysiol 41 (1978) 933-947
28. Rossi D.J., Oshima T., and Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 (2000) 316-321
29. Sarantis M., and Attwell D. Glutamate uptake in mammalian retinal glia is voltage- and potassium-dependent. Brain Res 516 (1990) 322-325
30. Scholz J., and Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10 (2007) 1361-1368
31. Shimada F., Shiga Y., Morikawa M., Kawazura H., Morikawa O., Matsuoka T., Nishizaki T., and Saito N. The neuroprotective agent MS-153 stimulates glutamate uptake. Eur J Pharmacol 386 (1999) 263-270
32. Simmons R.M., Webster A.A., Kalra A.B., and Iyengar S. Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol Biochem Behav 73 (2002) 419-427
33. Sung B., Lim G., and Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23 (2003) 2899-2910
34. Svendsen K.B., Jensen T.S., Hansen H.J., and Bach F.W. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 114 (2005) 473-481
35. Svendsen K.B., Jensen T.S., Overvad K., Hansen H.J., Koch-Henriksen N., and Bach F.W. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol 60 (2003) 1089-1094
36. Tao Y.X., Gu J., and Stephens Jr. R.L. Role of spinal cord glutamate transporter during normal sensory transmission and pathological pain states. Mol Pain 1 (2005) 30
37. Tilleux S., and Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85 (2007) 2059-2070
38. Tran K., and Leighton J.L. A simple, efficient, and highly enantioselective synthesis of MS-153 employing a chiral silane lewis acid-promoted acylhydrazone-enol ether [3 + 2] cycloaddition. Adv Synth Catal 348 (2006) 2431-2436
39. Vercellino M., Merola A., Piacentino C., Votta B., Capello E., Mancardi G.L., Mutani R., Giordana M.T., and Cavalla P. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 66 (2007) 732-739
40. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
41. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature 306 (1983) 686-688
42. Yamamoto T., Hirasawa S., Wroblewska B., Grajkowska E., Zhou J., Kozikowski A., Wroblewski J., and Neale J.H. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci 20 (2004) 483-494
43. Yashpal K., Fisher K., Chabot J.G., and Coderre T.J. Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats. Pain 94 (2001) 17-29
44. Zou X., Lin Q., and Willis W.D. Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats. J Neurosci 20 (2000) 6989-6997